Immunotherapy With Chemotherapy in the Maintenance of Remission in Acute Myeloblastic Leukaemia

Immunotherapy with BCG administered by scarification. Standardization of reactions and management of side effects

“…58 chemotherapy induced remissions16~'9~24~50~54. 59 and surviva1,5,7,16,19,22.24.36.38.39.47.50. 59 others have found no clinical effect over the same act role of nonspecific immunotherapy with BCG in human malignancies remains to be defined, several extensive clinical trials have been undertaken.…”

“…59 and surviva1,5,7,16,19,22.24.36.38.39.47.50. 59 others have found no clinical effect over the same act role of nonspecific immunotherapy with BCG in human malignancies remains to be defined, several extensive clinical trials have been undertaken. Several routes and schedules of administration have been employed by different investigators.…”